372 related articles for article (PubMed ID: 24044566)
1. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
2. Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children.
Boyraz M; Cekmez F; Karaoğlu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Jun; 7(3):423-8. PubMed ID: 23734806
[TBL] [Abstract][Full Text] [Related]
3. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
4. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
5. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
Huang SC; Yang YJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
[TBL] [Abstract][Full Text] [Related]
6. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
[TBL] [Abstract][Full Text] [Related]
7. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents.
Arslan N; Tokgoz Y; Kume T; Bulbul M; Sayın O; Harmancı D; Akdogan GG
J Pediatr Endocrinol Metab; 2013; 26(11-12):1141-7. PubMed ID: 23740679
[TBL] [Abstract][Full Text] [Related]
10. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
[TBL] [Abstract][Full Text] [Related]
11. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
Kashyap SR; Diab DL; Baker AR; Yerian L; Bajaj H; Gray-McGuire C; Schauer PR; Gupta M; Feldstein AE; Hazen SL; Stein CM
Obesity (Silver Spring); 2009 Sep; 17(9):1696-701. PubMed ID: 19360015
[TBL] [Abstract][Full Text] [Related]
13. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children.
Zou CC; Liang L; Hong F; Fu JF; Zhao ZY
Endocr J; 2005 Oct; 52(5):519-24. PubMed ID: 16284427
[TBL] [Abstract][Full Text] [Related]
15. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
16. Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance.
Pagano C; Soardo G; Pilon C; Milocco C; Basan L; Milan G; Donnini D; Faggian D; Mussap M; Plebani M; Avellini C; Federspil G; Sechi LA; Vettor R
J Clin Endocrinol Metab; 2006 Mar; 91(3):1081-6. PubMed ID: 16394091
[TBL] [Abstract][Full Text] [Related]
17. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
[TBL] [Abstract][Full Text] [Related]
18. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
Argentou M; Tiniakos DG; Karanikolas M; Melachrinou M; Makri MG; Kittas C; Kalfarentzos F
Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638
[TBL] [Abstract][Full Text] [Related]
19. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
20. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation.
Jialal I; Adams-Huet B; Duong F; Smith G
Metab Syndr Relat Disord; 2014 May; 12(4):227-30. PubMed ID: 24593134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
